David P. Harrington
104 works · 8,768 citations · h-index 32
Top works
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
- Counting Processes and Survival Analysis.
- A Class of Rank Test Procedures for Censored Survival Data
- Designs for group sequential tests
- The Design and Analysis of Sequential Clinical Trials.
- Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
- Identification of Major Prognostic Subgroups of Patients with Large-Cell Lymphoma Treated with m-BACOD or M-BACOD
- Modified Kolmogorov-Smirnov Test Procedures with Application to Arbitrarily Right-Censored Data
- Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma
- Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission
- Clinical and biologic implications of recurrent genomic aberrations in myeloma
- Regression Splines in the Cox Model with Application to Covariate Effects in Liver Disease
- A class of hypothesis tests for one and two sample censored survival data
- Generalized Estimating Equations for Correlated Binary Data: Using the Odds Ratio as a Measure of Association
- Varying intensity of postremission therapy in acute myeloid leukemia
- Understanding Cancer Treatment and Outcomes: The Cancer Care Outcomes Research and Surveillance Consortium
- The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.
- Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients
- Remissions in Hairy-Cell Leukemia with Pentostatin (2′-Deoxycoformycin)
- Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.